{"gene":"ARX","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2002,"finding":"ARX loss-of-function causes suppressed forebrain neuronal proliferation and aberrant migration/differentiation of GABAergic interneurons in the ganglionic eminence and neocortex, establishing ARX as essential for interneuron development and forebrain formation.","method":"Knockout mouse phenotypic analysis (loss-of-function); human mutation identification","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO mouse with defined cellular phenotypes, replicated in human loss-of-function mutations, foundational paper cited extensively","pmids":["12379852"],"is_preprint":false},{"year":2003,"finding":"Arx is required for pancreatic alpha-cell fate acquisition; Arx-deficient mice lose mature alpha cells with concomitant increase in beta- and delta-cell numbers. Arx and Pax4 act as transcriptional repressors of each other's expression, with antagonistic functions in islet cell specification.","method":"Gene targeting/knockout in mouse ES cells; immunohistology; multiplex RT-PCR","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined cellular phenotype and molecular epistasis demonstrated by transcript accumulation in reciprocal mutants","pmids":["14561778"],"is_preprint":false},{"year":2007,"finding":"Arx gain-of-function (misexpression) in embryonic or adult beta cells promotes conversion to glucagon- or PP-producing cells, confirming Arx is not only necessary but sufficient to instruct alpha/PP cell fate and suppress beta- and delta-cell identity.","method":"Conditional gain-of-function mouse; lineage tracing; quantitative RT-PCR","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain-of-function with lineage tracing, multiple orthogonal methods confirming cell fate conversion","pmids":["17404619"],"is_preprint":false},{"year":2005,"finding":"Combined loss of Arx and Pax4 results in near-exclusive generation of somatostatin-producing cells at the expense of alpha- and beta-cells, and both proteins act as transcriptional repressors controlling each other's expression levels to mediate proper endocrine fate allocation.","method":"Double-mutant mouse genetic epistasis; immunohistology; molecular analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double-mutant analysis, defined cellular phenotype with molecular mechanism of mutual repression","pmids":["15930104"],"is_preprint":false},{"year":2008,"finding":"Arx is a direct transcriptional target of Dlx2: Dlx overexpression induces ectopic Arx expression through a GABAergic enhancer element, loss of Dlx reduces Arx expression, and Arx is necessary (but not sufficient) for the Dlx-dependent promotion of interneuron tangential migration. Ultraconserved enhancer modules downstream of the Arx coding region, partially within introns of PolA1, control its forebrain expression.","method":"Enhancer isolation; functional characterization; Dlx gain/loss-of-function; combined mutant analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct enhancer functional characterization plus genetic epistasis with gain- and loss-of-function in Dlx mutant tissues","pmids":["18923043"],"is_preprint":false},{"year":2008,"finding":"Arx plays cell-autonomous roles in cortical development: ARX knockdown causes premature cell-cycle exit of cortical progenitors and impairs multipolar morphology and radial/tangential migration; ARX overexpression increases cell-cycle length and promotes tangential processes. ARX level is critical for tangential migration of GABAergic interneurons but is not directly required for GABAergic cell fate specification.","method":"In utero electroporation with RNAi knockdown and overexpression; live imaging; cell morphology analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-autonomous in utero electroporation with bidirectional perturbation (KD and OE) and defined cellular phenotypes","pmids":["18509041"],"is_preprint":false},{"year":2008,"finding":"Arx inactivation in the ventral telencephalon causes periventricular accumulation of immature neurons due to cell-autonomous defects in neuronal migration, impairs cholinergic neuron formation, and disrupts thalamocortical projections. Arx mutant neurons retain differentiation potential in vitro but show deficits in morphology and migration.","method":"Arx mutant mouse analysis; in vitro neuronal culture; immunohistochemistry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive mutant mouse analysis with in vitro validation establishing cell-autonomous migration defects","pmids":["17460091"],"is_preprint":false},{"year":2008,"finding":"ARX directly represses transcription of Lmo1, Ebf3, and Shox2 in the developing basal forebrain; genome-wide expression screen identified 84 dysregulated genes in the Arx-deficient subpallium enriched for cell migration, axonal guidance, and neurogenesis.","method":"Genome-wide expression screen; chromatin analysis; validation of direct repression","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide screen plus validation of direct repression of three targets, single lab","pmids":["18799476"],"is_preprint":false},{"year":2009,"finding":"Conditional deletion of Arx from ganglionic eminence-derived neurons (via Dlx5/6-CRE) causes multiple seizure types including infantile spasm-like events, demonstrating that Arx function specifically in cortical interneurons underlies epilepsy pathogenesis. Heterozygous females with single mutant Arx allele also develop seizures.","method":"Conditional knockout (Cre-lox); EEG recordings; behavioral analysis","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with EEG-confirmed seizure phenotype, pathway placement of Arx in interneurons as epilepsy mechanism","pmids":["19439424"],"is_preprint":false},{"year":2004,"finding":"Polyalanine tract expansions in ARX lead to intranuclear protein aggregation forming filamentous nuclear inclusions, increased cell death, ubiquitination of inclusions, and recruitment of Hsp70. Co-expression of Hsp70 decreases inclusion formation. Mutant Arx also forms nuclear inclusions in mouse brain slices.","method":"Cell culture transfection; brain slice electroporation; immunofluorescence; ubiquitin staining; Hsp70 co-expression rescue","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (cell culture, brain slices, rescue experiment with Hsp70) in single rigorous study","pmids":["15533998"],"is_preprint":false},{"year":2011,"finding":"In pancreatic beta cells, the Arx locus is methylated and repressed via Dnmt1-dependent propagation of DNA methylation; the methylated region is bound by MeCP2 which recruits PRMT6, an enzyme that methylates histone H3R2 to repress Arx. Loss of Dnmt1 leads to Arx de-repression and beta-to-alpha cell conversion.","method":"Conditional Dnmt1 knockout; bisulfite sequencing; ChIP; lineage tracing","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP identifying MeCP2 binding and PRMT6 recruitment at Arx locus plus functional KO with defined cell conversion, multiple orthogonal methods","pmids":["21497756"],"is_preprint":false},{"year":2011,"finding":"ARX homeodomain missense mutations causing brain malformations and infantile spasms abolish DNA binding and reduce transcriptional repression activity; the milder P353L mutation retains partial DNA binding and repression. Wild-type ARX represses endogenous targets LMO1 and SHOX2 by direct DNA binding confirmed by EMSA and ChIP.","method":"Luciferase reporter assays; EMSA; ChIP; qRT-PCR of endogenous targets","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — EMSA and ChIP confirming DNA binding, luciferase assays for repression activity, multiple mutations tested, correlating with clinical severity","pmids":["22194193"],"is_preprint":false},{"year":2009,"finding":"Arx acts as a regional key selector gene in the ventral telencephalon primarily through transcriptional repression. Ectopic expression of Ebf3 in ganglionic eminences prevents tangential migration; Arx directly represses Ebf3, and Ebf3 silencing in Arx mutants partially rescues tangential migration.","method":"Arx mutant mice; ectopic expression studies; epistasis rescue experiment","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with rescue of migration defect by Ebf3 silencing, establishing Arx→Ebf3 repression pathway","pmids":["19627984"],"is_preprint":false},{"year":2010,"finding":"Missense mutations in the nuclear localization sequences (NLS) flanking the ARX homeodomain disrupt nuclear accumulation. These mutations do not abolish binding to Importin 13 (IPO13); instead, mutant ARX sequesters endogenous IPO13 even in RanGTP-rich nuclear environments, preventing normal ARX distribution. ARX also interacts with TUBA1A (α-tubulin), and cells expressing mutant ARX accumulate in mitosis.","method":"Co-immunoprecipitation; immunofluorescence; cell cycle analysis","journal":"PathoGenetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and immunofluorescence for two interacting proteins (IPO13, TUBA1A), single lab with two orthogonal methods","pmids":["20148114"],"is_preprint":false},{"year":2013,"finding":"Selective inhibition of Arx in adult pancreatic alpha-cells is sufficient to promote their conversion into functional beta-like cells; this conversion induces mobilization of duct-lining precursor cells to adopt glucagon+ fate which then convert to beta-like cells. Pax4 is dispensable for this regeneration process, identifying Arx as the primary trigger.","method":"Conditional loss-of-function; lineage tracing; functional beta-cell characterization","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with lineage tracing and Arx/Pax4 double-mutant epistasis, functional characterization of converted cells","pmids":["24204325"],"is_preprint":false},{"year":2013,"finding":"ARX directly regulates Cdkn1c transcription in cortical progenitors; loss of Arx causes Cdkn1c overexpression which inhibits cell cycle progression, reducing intermediate progenitor cell expansion and upper-layer neuron formation.","method":"Cortex-specific conditional knockout; transcriptional profiling; direct regulatory relationship validated","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with transcriptome analysis and identification of direct target, single lab","pmids":["23968833"],"is_preprint":false},{"year":2014,"finding":"Lhx6 directly binds in vivo to an Arx enhancer (and a CXCR7 intronic enhancer) to regulate their expression. Arx rescues cell-fate but not laminar positioning defects in Lhx6-null MGE cells, establishing Lhx6→Arx as a direct transcriptional hierarchy for interneuron fate specification.","method":"In vivo ChIP at Arx enhancer; MGE transplantation/complementation assay; conditional genetics","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo ChIP demonstrating direct Lhx6 binding to Arx enhancer plus functional rescue by Arx in Lhx6-null cells","pmids":["24742460"],"is_preprint":false},{"year":2014,"finding":"Arx, in conjunction with FoxA2, directly induces Shh expression by binding to the Shh floor plate enhancer (SFPE2). FoxA2 induces Arx transcription while Nkx2.2 (induced by Shh) suppresses Arx, forming a feedback loop. Arx functions as a context-dependent transcriptional activator at this locus.","method":"In ovo chick electroporation (gain-of-function); Arx-deficient mouse (loss-of-function); enhancer binding assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional perturbation plus enhancer binding, single lab with two orthogonal approaches","pmids":["24968361"],"is_preprint":false},{"year":2011,"finding":"Islet-1 (Isl-1) directly activates Arx transcription in pancreatic alpha-cells through binding to two conserved noncoding regulatory regions (Re1 at +5.6-6.1 kb and Re2 at +23.6-24 kb) in the Arx locus; loss of Isl-1 reduces Arx-positive cell numbers and Arx mRNA levels.","method":"ChIP; cell transfection reporter assays; Isl-1 knockdown and overexpression; site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ChIP with site-directed mutagenesis of binding sites plus overexpression/knockdown, multiple orthogonal methods in single rigorous study","pmids":["21388963"],"is_preprint":false},{"year":2011,"finding":"ARX directly regulates KDM5C transcription by binding a conserved noncoding element in the KDM5C regulatory region. ARX polyalanine expansion mutations show decreased trans-activity and reduced binding to this element, correlating with reduced Kdm5c mRNA in Arx-knockout neural stem cells and altered H3K4me3 levels during neuronal differentiation.","method":"Reporter assays with ARX binding; qRT-PCR in Arx-KO cells; H3K4me3 measurement","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional binding assays plus epigenetic consequence measured, single lab, multiple methods","pmids":["23246292"],"is_preprint":false},{"year":2012,"finding":"ARX functions primarily as a transcriptional repressor: missense mutations in the homeodomain reduce or abolish DNA binding and transcriptional repression. DNA-binding preferences of ARX are influenced by amino acid sequences flanking the homeodomain; mutations affecting DNA binding also reduce repression of Arx target genes.","method":"In vitro DNA binding assays; luciferase repression reporter assays; deletion and missense mutant analysis","journal":"Neurogenetics","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assays with mutagenesis, single lab","pmids":["22252899"],"is_preprint":false},{"year":2013,"finding":"Polyalanine expansion mutations in ARX cause a marked reduction in Arx protein abundance in the developing forebrain without detectable protein aggregates; this reduced protein level correlates with impaired repression of target gene Lmo1, with greater loss of Lmo1 repression in the more severe PA1 (GCG7) expansion model than the PA2 (dup24) model.","method":"Knock-in mouse models; western blot; qRT-PCR of target gene expression","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two knock-in mouse models with protein quantification and target gene analysis, single lab","pmids":["24122442"],"is_preprint":false},{"year":2007,"finding":"Arx is strongly expressed in differentiating embryonic (but not fetal) skeletal muscle downstream of myogenic bHLH genes; it co-immunoprecipitates with Mef2C, enhances myogenic differentiation when overexpressed in C2C12 cells, stimulates Myogenin promoter activity and E-box-driven transcription with MyoD and Mef2C, and its absence causes delayed embryonic myoblast differentiation in vivo.","method":"Co-immunoprecipitation; C2C12 overexpression; reporter/promoter assays; Arx-deficient embryo analysis","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with Mef2C plus functional reporter assays and KO phenotype, single lab, multiple methods","pmids":["17932502"],"is_preprint":false},{"year":2017,"finding":"Combined loss of Arx and Dnmt1 in mouse alpha-cells drives extensive conversion of alpha cells into progeny resembling native beta cells, with converted cells acquiring beta-cell electrophysiology and glucose-stimulated insulin secretion. In human T1D patients, subsets of glucagon-expressing cells show loss of DNMT1 and ARX and produce insulin.","method":"Lineage tracing; single-cell RNA sequencing; electrophysiology; GSIS assays; human tissue immunostaining","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including scRNA-seq, electrophysiology, and functional assays; replicated in human tissue","pmids":["28215845"],"is_preprint":false},{"year":2020,"finding":"Postnatal Arx expression in parvalbumin interneurons (PVIs) regulates their functional properties; conditional postnatal ablation of Arx from PVIs increases theta oscillations, causes occasional seizures, elevated anxiety, and PVI hypoexcitability. Genome-wide sequencing of sorted PVIs identified Arx target genes associated with synaptic and extracellular matrix pathways.","method":"Conditional knockout (postnatal, PV-Cre); EEG recording; FACS-sorted cell RNA-seq; whole-cell patch-clamp recordings","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific conditional KO with EEG, electrophysiology, and genomic analysis, multiple orthogonal methods in single study","pmids":["33490907"],"is_preprint":false},{"year":2011,"finding":"Chromatin immunoprecipitation combined with microarray analysis identified ~1006 gene promoters bound by Arx in neuroblastoma cells and mouse embryonic brain; ~24% of bound genes showed expression changes on Arx overexpression or knockdown, defining a broad ARX gene regulatory network.","method":"ChIP-chip (chromatin immunoprecipitation with microarray); mRNA expression microarray; Arx overexpression and knockdown","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP with expression validation, single lab","pmids":["21966449"],"is_preprint":false},{"year":2005,"finding":"The C. elegans Arx ortholog alr-1 acts in a pathway with the LIM-homeodomain protein lin-11 (LIM1 ortholog) to regulate chemosensory neuron development, and alr-1 is required for differentiation of a GABAergic motoneuron subtype, demonstrating conservation of ARX function in GABAergic and sensory neuron development.","method":"C. elegans genetics; double mutant epistasis; neuronal cell fate analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in C. elegans with defined neuronal phenotypes, single model organism study","pmids":["15790968"],"is_preprint":false},{"year":2014,"finding":"Neonatal estradiol (E2) administration prevents spasms and seizures in Arx(GCG)10+7 mice by altering mRNA levels of three Arx downstream targets (Shox2, Ebf3, and Lgi1) and restoring depleted interneuron populations, establishing that early transcriptional changes downstream of Arx are sufficient for lasting disease modification.","method":"Pharmacological treatment (E2) in Arx mutant mice; EEG; interneuron counts; qRT-PCR of Arx targets","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue with molecular mechanism via target gene normalization, single lab","pmids":["24452264"],"is_preprint":false}],"current_model":"ARX is a paired-type homeodomain transcription factor that functions primarily as a transcriptional repressor (and context-dependent activator) of downstream target genes; it is required cell-autonomously for GABAergic interneuron tangential migration, cortical progenitor proliferation via Cdkn1c repression, and cholinergic neuron development in the forebrain, where it acts downstream of Dlx2 and Lhx6 through ultraconserved enhancers; in the pancreas, antagonistic interactions between ARX and PAX4—each repressing the other's transcription—determine alpha- versus beta/delta-cell fate, with ARX maintained in the off-state in beta cells by Dnmt1-MeCP2-PRMT6-mediated epigenetic silencing; disease-causing mutations either abolish DNA binding and transcriptional repression (homeodomain missense mutations causing lissencephaly), reduce protein abundance (polyalanine expansions causing interneuronopathy and epilepsy), or sequester the nuclear import receptor IPO13 preventing proper nuclear distribution."},"narrative":{"mechanistic_narrative":"ARX is a paired-type homeodomain transcription factor that orchestrates cell-fate specification and migration in two distinct developmental contexts: the forebrain and the pancreatic islet [PMID:12379852, PMID:14561778]. In the developing telencephalon, ARX is required cell-autonomously for tangential migration of ganglionic-eminence-derived GABAergic interneurons, cortical progenitor proliferation, and cholinergic neuron formation, acting downstream of Dlx2 and Lhx6, which bind ultraconserved forebrain enhancers in the ARX locus to drive its expression [PMID:18923043, PMID:18509041, PMID:17460091, PMID:24742460]. It functions principally as a sequence-specific transcriptional repressor, directly silencing Lmo1, Ebf3, Shox2, and the cell-cycle inhibitor Cdkn1c; de-repression of Ebf3 in ARX-deficient cells blocks interneuron migration, while loss of Cdkn1c repression causes premature progenitor cell-cycle exit [PMID:18799476, PMID:22194193, PMID:19627984, PMID:23968833]. Loss of ARX function specifically in cortical interneurons produces seizures and infantile-spasm-like events, and postnatal ARX in parvalbumin interneurons further tunes their excitability [PMID:19439424, PMID:33490907]. In the pancreas, ARX is necessary and sufficient to instruct alpha/PP-cell fate while suppressing beta- and delta-cell identity through mutually repressive antagonism with PAX4; in beta cells, the ARX locus is held silent by Dnmt1-dependent DNA methylation, MeCP2 binding, and PRMT6-mediated H3R2 methylation, and combined loss of ARX and Dnmt1 converts alpha cells into functional insulin-secreting beta-like cells [PMID:14561778, PMID:17404619, PMID:15930104, PMID:21497756, PMID:28215845]. Disease mechanisms are stratified by mutation class: homeodomain missense mutations abolish DNA binding and repression (lissencephaly), polyalanine expansions reduce ARX protein abundance and target repression (interneuronopathy and epilepsy), and NLS mutations sequester the import receptor IPO13 to disrupt nuclear distribution [PMID:22194193, PMID:20148114, PMID:24122442]. ARX can also act as a context-dependent activator, cooperating with FoxA2 to induce Shh at a floor-plate enhancer [PMID:24968361].","teleology":[{"year":2002,"claim":"Established ARX as essential for forebrain development by defining its requirement for GABAergic interneuron migration and neuronal proliferation, framing it as the molecular basis of a human brain malformation syndrome.","evidence":"Knockout mouse phenotypic analysis with human mutation identification","pmids":["12379852"],"confidence":"High","gaps":["Direct transcriptional targets not yet identified","Upstream regulators of Arx expression unknown"]},{"year":2003,"claim":"Extended ARX function beyond brain to the pancreatic islet, showing it specifies alpha-cell fate through mutual transcriptional repression with PAX4.","evidence":"Gene-targeted knockout mouse, immunohistology, multiplex RT-PCR","pmids":["14561778"],"confidence":"High","gaps":["Direct binding to the Pax4 locus not demonstrated","Cofactors mediating repression unknown"]},{"year":2005,"claim":"Resolved the combinatorial logic of islet fate allocation by showing Arx and Pax4 together gate alpha/beta versus delta-cell identity, and conserved ARX neuronal function in an invertebrate.","evidence":"Mouse double-mutant genetic epistasis; C. elegans alr-1/lin-11 genetics","pmids":["15930104","15790968"],"confidence":"High","gaps":["Mechanism of somatostatin-cell default fate not defined","Direct vs indirect cross-repression unresolved"]},{"year":2007,"claim":"Demonstrated ARX is sufficient, not merely necessary, to instruct alpha/PP fate, and revealed a separate role promoting embryonic myoblast differentiation via Mef2C.","evidence":"Conditional gain-of-function mouse with lineage tracing; C2C12 overexpression and Co-IP with Mef2C","pmids":["17404619","17932502"],"confidence":"High","gaps":["Muscle role rests on single lab","Whether activation vs repression underlies myogenic effect unclear"]},{"year":2008,"claim":"Placed ARX within a transcriptional hierarchy downstream of Dlx2 via ultraconserved enhancers and defined cell-autonomous progenitor proliferation and migration roles, plus its first direct repression targets.","evidence":"Enhancer functional characterization, Dlx gain/loss-of-function, in utero electroporation, genome-wide expression screen","pmids":["18923043","18509041","17460091","18799476"],"confidence":"High","gaps":["Repressive cofactor complexes not identified","Direct binding for most dysregulated genes not confirmed"]},{"year":2009,"claim":"Causally linked ARX loss in interneurons to epilepsy and identified Ebf3 de-repression as a migration-blocking mechanism rescuable by Ebf3 silencing.","evidence":"Dlx5/6-CRE conditional knockout with EEG; ectopic-expression and epistasis rescue","pmids":["19439424","19627984"],"confidence":"High","gaps":["Full set of seizure-relevant targets unresolved","Circuit-level mechanism of spasms not defined"]},{"year":2010,"claim":"Defined a nuclear-import disease mechanism in which NLS mutations sequester IPO13, and identified TUBA1A interaction with a mitotic accumulation phenotype.","evidence":"Co-immunoprecipitation, immunofluorescence, cell-cycle analysis","pmids":["20148114"],"confidence":"Medium","gaps":["TUBA1A interaction not reciprocally validated","Functional consequence of mitotic accumulation in vivo unknown"]},{"year":2011,"claim":"Established the epigenetic logic silencing Arx in beta cells (Dnmt1-MeCP2-PRMT6), mapped upstream activators (Isl-1) and a genome-wide ARX regulatory network, and identified KDM5C as a target linking ARX to histone methylation.","evidence":"Conditional Dnmt1 KO with ChIP and lineage tracing; Isl-1 ChIP and mutagenesis; ChIP-chip in neuroblastoma/brain; KDM5C reporter and H3K4me3 assays","pmids":["21497756","21388963","21966449","23246292"],"confidence":"High","gaps":["Direct ARX targets among ChIP-chip bound promoters mostly unvalidated","Generality of epigenetic silencing model beyond beta cells unclear"]},{"year":2012,"claim":"Defined ARX biochemically as a repressor whose DNA-binding specificity depends on homeodomain-flanking residues, mechanistically explaining how homeodomain missense mutations cause disease.","evidence":"In vitro DNA-binding and luciferase repression assays with mutant analysis","pmids":["22252899","22194193"],"confidence":"High","gaps":["Structural basis of flanking-residue contribution not resolved","Genome-wide binding motif not derived"]},{"year":2013,"claim":"Mechanistically separated polyalanine-expansion pathology (reduced protein abundance impairing Lmo1 repression) from earlier aggregation models, identified Cdkn1c as a direct proliferation target, and established Arx inhibition alone as sufficient to trigger alpha-to-beta cell regeneration.","evidence":"Knock-in mouse models with western blot; cortex-specific conditional KO with profiling; conditional alpha-cell loss-of-function with lineage tracing","pmids":["24122442","23968833","24204325"],"confidence":"Medium","gaps":["Reconciliation of aggregation vs abundance-loss models incomplete","Cdkn1c regulation rests on single lab"]},{"year":2014,"claim":"Placed ARX downstream of Lhx6 in interneuron fate, revealed a context-dependent activator role with FoxA2 at the Shh floor-plate enhancer, and showed early target normalization (by estradiol) yields lasting seizure rescue.","evidence":"In vivo ChIP and MGE complementation; chick/mouse Shh enhancer perturbation; pharmacological E2 rescue with target qRT-PCR","pmids":["24742460","24968361","24452264"],"confidence":"Medium","gaps":["Switch between repressor and activator modes mechanistically undefined","Cofactors converting ARX to an activator unknown"]},{"year":2017,"claim":"Demonstrated that combined ARX and Dnmt1 loss produces functional beta-like cells and that this conversion occurs in human type 1 diabetes islets, establishing translational relevance of ARX-controlled cell identity.","evidence":"Lineage tracing, scRNA-seq, electrophysiology, GSIS, human tissue immunostaining","pmids":["28215845"],"confidence":"High","gaps":["Stability and durability of converted cells unresolved","Therapeutic targeting strategy not established"]},{"year":2020,"claim":"Showed ARX has an ongoing postnatal role tuning parvalbumin interneuron excitability and identifying synaptic/ECM target pathways, extending its function beyond developmental specification.","evidence":"Postnatal PV-Cre conditional knockout, EEG, FACS-RNA-seq, patch-clamp","pmids":["33490907"],"confidence":"High","gaps":["Direct vs indirect regulation of synaptic/ECM targets unconfirmed","Mechanism linking ARX loss to PVI hypoexcitability undefined"]},{"year":null,"claim":"How ARX switches between transcriptional repression and context-dependent activation, and which cofactor complexes mediate each mode at specific loci, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of ARX bound to DNA or cofactors","Identity of corepressor/coactivator complexes unknown","Genome-wide direct target set across tissues incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,7,11,12,15,17,20]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[11,17,18,19,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,13]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,4,5,6,16]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,11,12,15,20,25]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,24]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[10,19]}],"complexes":[],"partners":["PAX4","IPO13","TUBA1A","MEF2C","DLX2","LHX6","FOXA2","ISL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96QS3","full_name":"Homeobox protein ARX","aliases":["Aristaless-related homeobox"],"length_aa":562,"mass_kda":58.2,"function":"Transcription factor (PubMed:22194193, PubMed:31691806). Binds to specific sequence motif 5'-TAATTA-3' in regulatory elements of target genes, such as histone demethylase KDM5C (PubMed:22194193, PubMed:31691806). Positively modulates transcription of KDM5C (PubMed:31691806). Activates expression of KDM5C synergistically with histone lysine demethylase PHF8 and perhaps in competition with transcription regulator ZNF711; synergy may be related to enrichment of histone H3K4me3 in regulatory elements (PubMed:31691806). Required for normal brain development (PubMed:11889467, PubMed:12379852, PubMed:14722918). Plays a role in neuronal proliferation, interneuronal migration and differentiation in the embryonic forebrain (By similarity). May also be involved in axonal guidance in the floor plate (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96QS3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARX","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ARX","total_profiled":1310},"omim":[{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"},{"mim_id":"617330","title":"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS","url":"https://www.omim.org/entry/617330"},{"mim_id":"614969","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7","url":"https://www.omim.org/entry/614969"},{"mim_id":"607432","title":"LISSENCEPHALY 1; LIS1","url":"https://www.omim.org/entry/607432"},{"mim_id":"607407","title":"EARLY B-CELL FACTOR 3; EBF3","url":"https://www.omim.org/entry/607407"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"ovary","ntpm":77.7},{"tissue":"skeletal muscle","ntpm":25.0}],"url":"https://www.proteinatlas.org/search/ARX"},"hgnc":{"alias_symbol":["ISSX","CT121","EIEE1"],"prev_symbol":["MRXS1","PRTS","MRX76","MRX54","MRX43","MRX36","MRX29","MRX32","MRX33","MRX38","MRX87"]},"alphafold":{"accession":"Q96QS3","domains":[{"cath_id":"1.10.10.60","chopping":"344-387","consensus_level":"high","plddt":96.6964,"start":344,"end":387}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96QS3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96QS3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96QS3-F1-predicted_aligned_error_v6.png","plddt_mean":55.03},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARX","jax_strain_url":"https://www.jax.org/strain/search?query=ARX"},"sequence":{"accession":"Q96QS3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96QS3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96QS3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96QS3"}},"corpus_meta":[{"pmid":"12379852","id":"PMC_12379852","title":"Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12379852","citation_count":526,"is_preprint":false},{"pmid":"14561778","id":"PMC_14561778","title":"Opposing actions of Arx and Pax4 in endocrine pancreas development.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14561778","citation_count":454,"is_preprint":false},{"pmid":"11971879","id":"PMC_11971879","title":"ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11971879","citation_count":233,"is_preprint":false},{"pmid":"14722918","id":"PMC_14722918","title":"Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14722918","citation_count":232,"is_preprint":false},{"pmid":"24204325","id":"PMC_24204325","title":"The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24204325","citation_count":213,"is_preprint":false},{"pmid":"21497756","id":"PMC_21497756","title":"Pancreatic β cell identity is maintained by DNA methylation-mediated repression of Arx.","date":"2011","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/21497756","citation_count":210,"is_preprint":false},{"pmid":"17404619","id":"PMC_17404619","title":"Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression.","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17404619","citation_count":204,"is_preprint":false},{"pmid":"15930104","id":"PMC_15930104","title":"The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15930104","citation_count":175,"is_preprint":false},{"pmid":"28215845","id":"PMC_28215845","title":"Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.","date":"2017","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28215845","citation_count":171,"is_preprint":false},{"pmid":"19439424","id":"PMC_19439424","title":"Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.","date":"2009","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19439424","citation_count":158,"is_preprint":false},{"pmid":"12142061","id":"PMC_12142061","title":"Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARX.","date":"2002","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/12142061","citation_count":152,"is_preprint":false},{"pmid":"9256348","id":"PMC_9256348","title":"Expression of a novel aristaless related homeobox gene 'Arx' in the vertebrate telencephalon, diencephalon and floor plate.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9256348","citation_count":151,"is_preprint":false},{"pmid":"19587282","id":"PMC_19587282","title":"A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19587282","citation_count":138,"is_preprint":false},{"pmid":"17668384","id":"PMC_17668384","title":"A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome).","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17668384","citation_count":133,"is_preprint":false},{"pmid":"20506206","id":"PMC_20506206","title":"ARX spectrum disorders: making inroads into the molecular pathology.","date":"2010","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/20506206","citation_count":129,"is_preprint":false},{"pmid":"9347917","id":"PMC_9347917","title":"Expression patterns of Brx1 (Rieg gene), Sonic hedgehog, Nkx2.2, Dlx1 and Arx during zona limitans intrathalamica and embryonic ventral lateral geniculate nuclear formation.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9347917","citation_count":121,"is_preprint":false},{"pmid":"18923043","id":"PMC_18923043","title":"Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18923043","citation_count":120,"is_preprint":false},{"pmid":"17664401","id":"PMC_17664401","title":"Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17664401","citation_count":115,"is_preprint":false},{"pmid":"17460091","id":"PMC_17460091","title":"Inactivation of Arx, the murine ortholog of the X-linked lissencephaly with ambiguous genitalia gene, leads to severe disorganization of the ventral telencephalon with impaired neuronal migration and differentiation.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17460091","citation_count":114,"is_preprint":false},{"pmid":"18799476","id":"PMC_18799476","title":"Identification of Arx transcriptional targets in the developing basal forebrain.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18799476","citation_count":110,"is_preprint":false},{"pmid":"16650978","id":"PMC_16650978","title":"ARX: a gene for all seasons.","date":"2006","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/16650978","citation_count":109,"is_preprint":false},{"pmid":"14631200","id":"PMC_14631200","title":"The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes.","date":"2003","source":"Current opinion in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/14631200","citation_count":105,"is_preprint":false},{"pmid":"24742460","id":"PMC_24742460","title":"Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24742460","citation_count":102,"is_preprint":false},{"pmid":"18509041","id":"PMC_18509041","title":"Cell-autonomous roles of ARX in cell proliferation and neuronal migration during corticogenesis.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18509041","citation_count":97,"is_preprint":false},{"pmid":"15677725","id":"PMC_15677725","title":"Arx homeobox gene is essential for development of mouse olfactory system.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15677725","citation_count":94,"is_preprint":false},{"pmid":"12376946","id":"PMC_12376946","title":"Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12376946","citation_count":94,"is_preprint":false},{"pmid":"20300201","id":"PMC_20300201","title":"Mutations in ARX Result in Several Defects Involving GABAergic Neurons.","date":"2010","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20300201","citation_count":90,"is_preprint":false},{"pmid":"15319782","id":"PMC_15319782","title":"Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations.","date":"2004","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15319782","citation_count":83,"is_preprint":false},{"pmid":"22570716","id":"PMC_22570716","title":"The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22570716","citation_count":78,"is_preprint":false},{"pmid":"12177367","id":"PMC_12177367","title":"X-linked myoclonic epilepsy with spasticity and intellectual disability: mutation in the homeobox gene ARX.","date":"2002","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12177367","citation_count":77,"is_preprint":false},{"pmid":"14992814","id":"PMC_14992814","title":"Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons.","date":"2004","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/14992814","citation_count":75,"is_preprint":false},{"pmid":"23785486","id":"PMC_23785486","title":"Pancreatic α-cell specific deletion of mouse Arx leads to α-cell identity loss.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23785486","citation_count":74,"is_preprint":false},{"pmid":"15533998","id":"PMC_15533998","title":"A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15533998","citation_count":74,"is_preprint":false},{"pmid":"16519652","id":"PMC_16519652","title":"The role of ARX in cortical development.","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/16519652","citation_count":71,"is_preprint":false},{"pmid":"15376319","id":"PMC_15376319","title":"Mouse orthologue of ARX, a gene mutated in several X-linked forms of mental retardation and epilepsy, is a marker of adult neural stem cells and forebrain GABAergic neurons.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15376319","citation_count":70,"is_preprint":false},{"pmid":"19605412","id":"PMC_19605412","title":"Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19605412","citation_count":70,"is_preprint":false},{"pmid":"12874405","id":"PMC_12874405","title":"ARX mutations in X-linked lissencephaly with abnormal genitalia.","date":"2003","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12874405","citation_count":63,"is_preprint":false},{"pmid":"12427933","id":"PMC_12427933","title":"Cell-wall proteinases PrtS and PrtB have a different role in Streptococcus thermophilus/Lactobacillus bulgaricus mixed cultures in milk.","date":"2002","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12427933","citation_count":62,"is_preprint":false},{"pmid":"22387004","id":"PMC_22387004","title":"Arx is required for normal enteroendocrine cell development in mice and humans.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22387004","citation_count":62,"is_preprint":false},{"pmid":"22565167","id":"PMC_22565167","title":"Interneuron, interrupted: molecular pathogenesis of ARX mutations and X-linked infantile spasms.","date":"2012","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22565167","citation_count":58,"is_preprint":false},{"pmid":"19268445","id":"PMC_19268445","title":"The Xenopus Irx genes are essential for neural patterning and define the border between prethalamus and thalamus through mutual antagonism with the anterior repressors Fezf and Arx.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19268445","citation_count":57,"is_preprint":false},{"pmid":"24452264","id":"PMC_24452264","title":"Neonatal estradiol stimulation prevents epilepsy in Arx model of X-linked infantile spasms syndrome.","date":"2014","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24452264","citation_count":56,"is_preprint":false},{"pmid":"12359145","id":"PMC_12359145","title":"Human ARX gene: genomic characterization and expression.","date":"2002","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12359145","citation_count":55,"is_preprint":false},{"pmid":"23840809","id":"PMC_23840809","title":"Aristaless related homeobox gene, Arx, is implicated in mouse fetal Leydig cell differentiation possibly through expressing in the progenitor cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23840809","citation_count":55,"is_preprint":false},{"pmid":"15200506","id":"PMC_15200506","title":"Three new families with X-linked mental retardation caused by the 428-451dup(24bp) mutation in ARX.","date":"2004","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15200506","citation_count":55,"is_preprint":false},{"pmid":"23968833","id":"PMC_23968833","title":"ARX regulates cortical intermediate progenitor cell expansion and upper layer neuron formation through repression of Cdkn1c.","date":"2013","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/23968833","citation_count":54,"is_preprint":false},{"pmid":"15199382","id":"PMC_15199382","title":"Screening of the ARX gene in 682 retarded males.","date":"2004","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15199382","citation_count":49,"is_preprint":false},{"pmid":"22355284","id":"PMC_22355284","title":"Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation.","date":"2011","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22355284","citation_count":47,"is_preprint":false},{"pmid":"19627984","id":"PMC_19627984","title":"Arx acts as a regional key selector gene in the ventral telencephalon mainly through its transcriptional repression activity.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19627984","citation_count":47,"is_preprint":false},{"pmid":"21995822","id":"PMC_21995822","title":"The fast milk acidifying phenotype of Streptococcus thermophilus can be acquired by natural transformation of the genomic island encoding the cell-envelope proteinase PrtS.","date":"2011","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/21995822","citation_count":46,"is_preprint":false},{"pmid":"16235064","id":"PMC_16235064","title":"Screening of ARX in mental retardation families: Consequences for the strategy of molecular diagnosis.","date":"2005","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16235064","citation_count":41,"is_preprint":false},{"pmid":"22628459","id":"PMC_22628459","title":"An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development.","date":"2012","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22628459","citation_count":41,"is_preprint":false},{"pmid":"21856296","id":"PMC_21856296","title":"Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21856296","citation_count":40,"is_preprint":false},{"pmid":"27287386","id":"PMC_27287386","title":"Developmental interneuron subtype deficits after targeted loss of Arx.","date":"2016","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27287386","citation_count":40,"is_preprint":false},{"pmid":"23246292","id":"PMC_23246292","title":"A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23246292","citation_count":38,"is_preprint":false},{"pmid":"15790968","id":"PMC_15790968","title":"Regulation of chemosensory and GABAergic motor neuron development by the C. elegans Aristaless/Arx homolog alr-1.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15790968","citation_count":36,"is_preprint":false},{"pmid":"21966449","id":"PMC_21966449","title":"High-throughput analysis of promoter occupancy reveals new targets for Arx, a gene mutated in mental retardation and interneuronopathies.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21966449","citation_count":34,"is_preprint":false},{"pmid":"22728160","id":"PMC_22728160","title":"Analysis of transcriptional codes for zebrafish dopaminergic neurons reveals essential functions of Arx and Isl1 in prethalamic dopaminergic neuron development.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22728160","citation_count":34,"is_preprint":false},{"pmid":"21388963","id":"PMC_21388963","title":"Islet-1 regulates Arx transcription during pancreatic islet alpha-cell development.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21388963","citation_count":33,"is_preprint":false},{"pmid":"24794919","id":"PMC_24794919","title":"Conditional Loss of Arx From the Developing Dorsal Telencephalon Results in Behavioral Phenotypes Resembling Mild Human ARX Mutations.","date":"2014","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/24794919","citation_count":33,"is_preprint":false},{"pmid":"20148114","id":"PMC_20148114","title":"Mutations in the nuclear localization sequence of the Aristaless related homeobox; sequestration of mutant ARX with IPO13 disrupts normal subcellular distribution of the transcription factor and retards cell division.","date":"2010","source":"PathoGenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20148114","citation_count":33,"is_preprint":false},{"pmid":"19747203","id":"PMC_19747203","title":"A novel ARX phenotype: rapid neurodegeneration with Ohtahara syndrome and a dyskinetic movement disorder.","date":"2010","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19747203","citation_count":33,"is_preprint":false},{"pmid":"26633894","id":"PMC_26633894","title":"The Role of ARX in Human Pancreatic Endocrine Specification.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26633894","citation_count":32,"is_preprint":false},{"pmid":"16523516","id":"PMC_16523516","title":"The ARX mutations: a frequent cause of X-linked mental retardation.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/16523516","citation_count":29,"is_preprint":false},{"pmid":"20384723","id":"PMC_20384723","title":"Frameshift mutations of the ARX gene in familial Ohtahara syndrome.","date":"2010","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/20384723","citation_count":29,"is_preprint":false},{"pmid":"31175998","id":"PMC_31175998","title":"The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia.","date":"2019","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/31175998","citation_count":29,"is_preprint":false},{"pmid":"15707237","id":"PMC_15707237","title":"The phenotypic spectrum of ARX mutations.","date":"2005","source":"Developmental medicine and child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15707237","citation_count":28,"is_preprint":false},{"pmid":"17932502","id":"PMC_17932502","title":"The homeobox gene Arx is a novel positive regulator of embryonic myogenesis.","date":"2007","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/17932502","citation_count":28,"is_preprint":false},{"pmid":"19738637","id":"PMC_19738637","title":"Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C>G/p.Y27X).","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19738637","citation_count":27,"is_preprint":false},{"pmid":"18462864","id":"PMC_18462864","title":"Expansion of the ARX spectrum.","date":"2008","source":"Clinical neurology and neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/18462864","citation_count":27,"is_preprint":false},{"pmid":"35483359","id":"PMC_35483359","title":"NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the Drosophila central brain and visual system.","date":"2022","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/35483359","citation_count":27,"is_preprint":false},{"pmid":"18468866","id":"PMC_18468866","title":"Combination of infantile spasms, non-epileptic seizures and complex movement disorder: a new case of ARX-related epilepsy.","date":"2008","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/18468866","citation_count":27,"is_preprint":false},{"pmid":"31846235","id":"PMC_31846235","title":"Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.","date":"2019","source":"Diagnostic cytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/31846235","citation_count":27,"is_preprint":false},{"pmid":"21204215","id":"PMC_21204215","title":"ARX polyalanine expansions are highly implicated in familial cases of mental retardation with infantile epilepsy and/or hand dystonia.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21204215","citation_count":27,"is_preprint":false},{"pmid":"24968361","id":"PMC_24968361","title":"Arx together with FoxA2, regulates Shh floor plate expression.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24968361","citation_count":25,"is_preprint":false},{"pmid":"21880149","id":"PMC_21880149","title":"Arx and Nkx2.2 compound deficiency redirects pancreatic alpha- and beta-cell differentiation to a somatostatin/ghrelin co-expressing cell lineage.","date":"2011","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21880149","citation_count":25,"is_preprint":false},{"pmid":"7943040","id":"PMC_7943040","title":"X-linked mental retardation with dystonic movements of the hands (PRTS): revisited.","date":"1994","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7943040","citation_count":24,"is_preprint":false},{"pmid":"22194193","id":"PMC_22194193","title":"ARX homeodomain mutations abolish DNA binding and lead to a loss of transcriptional repression.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22194193","citation_count":23,"is_preprint":false},{"pmid":"21496008","id":"PMC_21496008","title":"Screening and cell-based assessment of mutations in the Aristaless-related homeobox (ARX) gene.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21496008","citation_count":23,"is_preprint":false},{"pmid":"17044103","id":"PMC_17044103","title":"Mutation screening of the ARX gene in patients with autism.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17044103","citation_count":22,"is_preprint":false},{"pmid":"36215135","id":"PMC_36215135","title":"Multifunctional Bioactive Scaffolds from ARX-g-(Zn@rGO)-HAp for Bone Tissue Engineering: In Vitro Antibacterial, Antitumor, and Biocompatibility Evaluations.","date":"2022","source":"ACS applied bio materials","url":"https://pubmed.ncbi.nlm.nih.gov/36215135","citation_count":22,"is_preprint":false},{"pmid":"21108397","id":"PMC_21108397","title":"Familial Ohtahara syndrome due to a novel ARX gene mutation.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21108397","citation_count":22,"is_preprint":false},{"pmid":"21426321","id":"PMC_21426321","title":"A novel mutation in the aristaless domain of the ARX gene leads to Ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females.","date":"2011","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/21426321","citation_count":22,"is_preprint":false},{"pmid":"21479374","id":"PMC_21479374","title":"Disruption of the IQSEC2 transcript in a female with X;autosome translocation t(X;20)(p11.2;q11.2) and a phenotype resembling X-linked infantile spasms (ISSX) syndrome.","date":"2008","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/21479374","citation_count":22,"is_preprint":false},{"pmid":"33065381","id":"PMC_33065381","title":"Streptococcus thermophilus growth in soya milk: Sucrose consumption, nitrogen metabolism, soya protein hydrolysis and role of the cell-wall protease PrtS.","date":"2020","source":"International journal of food microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33065381","citation_count":21,"is_preprint":false},{"pmid":"24122442","id":"PMC_24122442","title":"Reduced polyalanine-expanded Arx mutant protein in developing mouse subpallium alters Lmo1 transcriptional regulation.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24122442","citation_count":21,"is_preprint":false},{"pmid":"20538404","id":"PMC_20538404","title":"Partial loss of pancreas endocrine and exocrine cells of human ARX-null mutation: consideration of pancreas differentiation.","date":"2010","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/20538404","citation_count":21,"is_preprint":false},{"pmid":"15850492","id":"PMC_15850492","title":"XLMR in MRX families 29, 32, 33 and 38 results from the dup24 mutation in the ARX (Aristaless related homeobox) gene.","date":"2005","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15850492","citation_count":20,"is_preprint":false},{"pmid":"16078051","id":"PMC_16078051","title":"Maternal mosaicism for mutations in the ARX gene in a family with X linked mental retardation.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16078051","citation_count":20,"is_preprint":false},{"pmid":"12689693","id":"PMC_12689693","title":"X-linked mental retardation and epilepsy: pathogenetic significance of ARX mutations.","date":"2003","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/12689693","citation_count":19,"is_preprint":false},{"pmid":"31191509","id":"PMC_31191509","title":"Arsenite Oxidation by a Newly Isolated Betaproteobacterium Possessing arx Genes and Diversity of the arx Gene Cluster in Bacterial Genomes.","date":"2019","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31191509","citation_count":19,"is_preprint":false},{"pmid":"29659809","id":"PMC_29659809","title":"A new mouse model of ARX dup24 recapitulates the patients' behavioral and fine motor alterations.","date":"2018","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29659809","citation_count":19,"is_preprint":false},{"pmid":"22252899","id":"PMC_22252899","title":"Distinct DNA binding and transcriptional repression characteristics related to different ARX mutations.","date":"2012","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/22252899","citation_count":18,"is_preprint":false},{"pmid":"26856418","id":"PMC_26856418","title":"Redifferentiation of expanded human islet β cells by inhibition of ARX.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26856418","citation_count":17,"is_preprint":false},{"pmid":"17082467","id":"PMC_17082467","title":"Genotype-phenotype associations for ARX gene duplication in X-linked mental retardation.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17082467","citation_count":17,"is_preprint":false},{"pmid":"27798109","id":"PMC_27798109","title":"Embryonic forebrain transcriptome of mice with polyalanine expansion mutations in the ARX homeobox gene.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27798109","citation_count":16,"is_preprint":false},{"pmid":"12536326","id":"PMC_12536326","title":"The Xenopus arx gene is expressed in the developing rostral forebrain.","date":"2002","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/12536326","citation_count":16,"is_preprint":false},{"pmid":"20036914","id":"PMC_20036914","title":"The aristaless (Arx) gene: one gene for many \"interneuronopathies\".","date":"2010","source":"Frontiers in bioscience (Elite edition)","url":"https://pubmed.ncbi.nlm.nih.gov/20036914","citation_count":15,"is_preprint":false},{"pmid":"33490907","id":"PMC_33490907","title":"Postnatal Arx transcriptional activity regulates functional properties of PV interneurons.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/33490907","citation_count":15,"is_preprint":false},{"pmid":"26029707","id":"PMC_26029707","title":"Unraveling the pathogenesis of ARX polyalanine tract variants using a clinical and molecular interfacing approach.","date":"2015","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26029707","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45999,"output_tokens":6406,"usd":0.117043,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":30820,"output_tokens":9400,"usd":0.288213,"resynth_parse_fail":true,"stage2_stop_reason":"end_turn"},"total_usd":0.405256,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"ARX loss-of-function causes suppressed forebrain neuronal proliferation and aberrant migration/differentiation of GABAergic interneurons in the ganglionic eminence and neocortex, establishing ARX as essential for interneuron development and forebrain formation.\",\n      \"method\": \"Knockout mouse phenotypic analysis (loss-of-function); human mutation identification\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO mouse with defined cellular phenotypes, replicated in human loss-of-function mutations, foundational paper cited extensively\",\n      \"pmids\": [\"12379852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Arx is required for pancreatic alpha-cell fate acquisition; Arx-deficient mice lose mature alpha cells with concomitant increase in beta- and delta-cell numbers. Arx and Pax4 act as transcriptional repressors of each other's expression, with antagonistic functions in islet cell specification.\",\n      \"method\": \"Gene targeting/knockout in mouse ES cells; immunohistology; multiplex RT-PCR\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined cellular phenotype and molecular epistasis demonstrated by transcript accumulation in reciprocal mutants\",\n      \"pmids\": [\"14561778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Arx gain-of-function (misexpression) in embryonic or adult beta cells promotes conversion to glucagon- or PP-producing cells, confirming Arx is not only necessary but sufficient to instruct alpha/PP cell fate and suppress beta- and delta-cell identity.\",\n      \"method\": \"Conditional gain-of-function mouse; lineage tracing; quantitative RT-PCR\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain-of-function with lineage tracing, multiple orthogonal methods confirming cell fate conversion\",\n      \"pmids\": [\"17404619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Combined loss of Arx and Pax4 results in near-exclusive generation of somatostatin-producing cells at the expense of alpha- and beta-cells, and both proteins act as transcriptional repressors controlling each other's expression levels to mediate proper endocrine fate allocation.\",\n      \"method\": \"Double-mutant mouse genetic epistasis; immunohistology; molecular analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double-mutant analysis, defined cellular phenotype with molecular mechanism of mutual repression\",\n      \"pmids\": [\"15930104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Arx is a direct transcriptional target of Dlx2: Dlx overexpression induces ectopic Arx expression through a GABAergic enhancer element, loss of Dlx reduces Arx expression, and Arx is necessary (but not sufficient) for the Dlx-dependent promotion of interneuron tangential migration. Ultraconserved enhancer modules downstream of the Arx coding region, partially within introns of PolA1, control its forebrain expression.\",\n      \"method\": \"Enhancer isolation; functional characterization; Dlx gain/loss-of-function; combined mutant analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct enhancer functional characterization plus genetic epistasis with gain- and loss-of-function in Dlx mutant tissues\",\n      \"pmids\": [\"18923043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Arx plays cell-autonomous roles in cortical development: ARX knockdown causes premature cell-cycle exit of cortical progenitors and impairs multipolar morphology and radial/tangential migration; ARX overexpression increases cell-cycle length and promotes tangential processes. ARX level is critical for tangential migration of GABAergic interneurons but is not directly required for GABAergic cell fate specification.\",\n      \"method\": \"In utero electroporation with RNAi knockdown and overexpression; live imaging; cell morphology analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-autonomous in utero electroporation with bidirectional perturbation (KD and OE) and defined cellular phenotypes\",\n      \"pmids\": [\"18509041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Arx inactivation in the ventral telencephalon causes periventricular accumulation of immature neurons due to cell-autonomous defects in neuronal migration, impairs cholinergic neuron formation, and disrupts thalamocortical projections. Arx mutant neurons retain differentiation potential in vitro but show deficits in morphology and migration.\",\n      \"method\": \"Arx mutant mouse analysis; in vitro neuronal culture; immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive mutant mouse analysis with in vitro validation establishing cell-autonomous migration defects\",\n      \"pmids\": [\"17460091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ARX directly represses transcription of Lmo1, Ebf3, and Shox2 in the developing basal forebrain; genome-wide expression screen identified 84 dysregulated genes in the Arx-deficient subpallium enriched for cell migration, axonal guidance, and neurogenesis.\",\n      \"method\": \"Genome-wide expression screen; chromatin analysis; validation of direct repression\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide screen plus validation of direct repression of three targets, single lab\",\n      \"pmids\": [\"18799476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Conditional deletion of Arx from ganglionic eminence-derived neurons (via Dlx5/6-CRE) causes multiple seizure types including infantile spasm-like events, demonstrating that Arx function specifically in cortical interneurons underlies epilepsy pathogenesis. Heterozygous females with single mutant Arx allele also develop seizures.\",\n      \"method\": \"Conditional knockout (Cre-lox); EEG recordings; behavioral analysis\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with EEG-confirmed seizure phenotype, pathway placement of Arx in interneurons as epilepsy mechanism\",\n      \"pmids\": [\"19439424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Polyalanine tract expansions in ARX lead to intranuclear protein aggregation forming filamentous nuclear inclusions, increased cell death, ubiquitination of inclusions, and recruitment of Hsp70. Co-expression of Hsp70 decreases inclusion formation. Mutant Arx also forms nuclear inclusions in mouse brain slices.\",\n      \"method\": \"Cell culture transfection; brain slice electroporation; immunofluorescence; ubiquitin staining; Hsp70 co-expression rescue\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (cell culture, brain slices, rescue experiment with Hsp70) in single rigorous study\",\n      \"pmids\": [\"15533998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In pancreatic beta cells, the Arx locus is methylated and repressed via Dnmt1-dependent propagation of DNA methylation; the methylated region is bound by MeCP2 which recruits PRMT6, an enzyme that methylates histone H3R2 to repress Arx. Loss of Dnmt1 leads to Arx de-repression and beta-to-alpha cell conversion.\",\n      \"method\": \"Conditional Dnmt1 knockout; bisulfite sequencing; ChIP; lineage tracing\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP identifying MeCP2 binding and PRMT6 recruitment at Arx locus plus functional KO with defined cell conversion, multiple orthogonal methods\",\n      \"pmids\": [\"21497756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARX homeodomain missense mutations causing brain malformations and infantile spasms abolish DNA binding and reduce transcriptional repression activity; the milder P353L mutation retains partial DNA binding and repression. Wild-type ARX represses endogenous targets LMO1 and SHOX2 by direct DNA binding confirmed by EMSA and ChIP.\",\n      \"method\": \"Luciferase reporter assays; EMSA; ChIP; qRT-PCR of endogenous targets\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — EMSA and ChIP confirming DNA binding, luciferase assays for repression activity, multiple mutations tested, correlating with clinical severity\",\n      \"pmids\": [\"22194193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Arx acts as a regional key selector gene in the ventral telencephalon primarily through transcriptional repression. Ectopic expression of Ebf3 in ganglionic eminences prevents tangential migration; Arx directly represses Ebf3, and Ebf3 silencing in Arx mutants partially rescues tangential migration.\",\n      \"method\": \"Arx mutant mice; ectopic expression studies; epistasis rescue experiment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with rescue of migration defect by Ebf3 silencing, establishing Arx→Ebf3 repression pathway\",\n      \"pmids\": [\"19627984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Missense mutations in the nuclear localization sequences (NLS) flanking the ARX homeodomain disrupt nuclear accumulation. These mutations do not abolish binding to Importin 13 (IPO13); instead, mutant ARX sequesters endogenous IPO13 even in RanGTP-rich nuclear environments, preventing normal ARX distribution. ARX also interacts with TUBA1A (α-tubulin), and cells expressing mutant ARX accumulate in mitosis.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence; cell cycle analysis\",\n      \"journal\": \"PathoGenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and immunofluorescence for two interacting proteins (IPO13, TUBA1A), single lab with two orthogonal methods\",\n      \"pmids\": [\"20148114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Selective inhibition of Arx in adult pancreatic alpha-cells is sufficient to promote their conversion into functional beta-like cells; this conversion induces mobilization of duct-lining precursor cells to adopt glucagon+ fate which then convert to beta-like cells. Pax4 is dispensable for this regeneration process, identifying Arx as the primary trigger.\",\n      \"method\": \"Conditional loss-of-function; lineage tracing; functional beta-cell characterization\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with lineage tracing and Arx/Pax4 double-mutant epistasis, functional characterization of converted cells\",\n      \"pmids\": [\"24204325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ARX directly regulates Cdkn1c transcription in cortical progenitors; loss of Arx causes Cdkn1c overexpression which inhibits cell cycle progression, reducing intermediate progenitor cell expansion and upper-layer neuron formation.\",\n      \"method\": \"Cortex-specific conditional knockout; transcriptional profiling; direct regulatory relationship validated\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with transcriptome analysis and identification of direct target, single lab\",\n      \"pmids\": [\"23968833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Lhx6 directly binds in vivo to an Arx enhancer (and a CXCR7 intronic enhancer) to regulate their expression. Arx rescues cell-fate but not laminar positioning defects in Lhx6-null MGE cells, establishing Lhx6→Arx as a direct transcriptional hierarchy for interneuron fate specification.\",\n      \"method\": \"In vivo ChIP at Arx enhancer; MGE transplantation/complementation assay; conditional genetics\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo ChIP demonstrating direct Lhx6 binding to Arx enhancer plus functional rescue by Arx in Lhx6-null cells\",\n      \"pmids\": [\"24742460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Arx, in conjunction with FoxA2, directly induces Shh expression by binding to the Shh floor plate enhancer (SFPE2). FoxA2 induces Arx transcription while Nkx2.2 (induced by Shh) suppresses Arx, forming a feedback loop. Arx functions as a context-dependent transcriptional activator at this locus.\",\n      \"method\": \"In ovo chick electroporation (gain-of-function); Arx-deficient mouse (loss-of-function); enhancer binding assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional perturbation plus enhancer binding, single lab with two orthogonal approaches\",\n      \"pmids\": [\"24968361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Islet-1 (Isl-1) directly activates Arx transcription in pancreatic alpha-cells through binding to two conserved noncoding regulatory regions (Re1 at +5.6-6.1 kb and Re2 at +23.6-24 kb) in the Arx locus; loss of Isl-1 reduces Arx-positive cell numbers and Arx mRNA levels.\",\n      \"method\": \"ChIP; cell transfection reporter assays; Isl-1 knockdown and overexpression; site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP with site-directed mutagenesis of binding sites plus overexpression/knockdown, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"21388963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARX directly regulates KDM5C transcription by binding a conserved noncoding element in the KDM5C regulatory region. ARX polyalanine expansion mutations show decreased trans-activity and reduced binding to this element, correlating with reduced Kdm5c mRNA in Arx-knockout neural stem cells and altered H3K4me3 levels during neuronal differentiation.\",\n      \"method\": \"Reporter assays with ARX binding; qRT-PCR in Arx-KO cells; H3K4me3 measurement\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional binding assays plus epigenetic consequence measured, single lab, multiple methods\",\n      \"pmids\": [\"23246292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARX functions primarily as a transcriptional repressor: missense mutations in the homeodomain reduce or abolish DNA binding and transcriptional repression. DNA-binding preferences of ARX are influenced by amino acid sequences flanking the homeodomain; mutations affecting DNA binding also reduce repression of Arx target genes.\",\n      \"method\": \"In vitro DNA binding assays; luciferase repression reporter assays; deletion and missense mutant analysis\",\n      \"journal\": \"Neurogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assays with mutagenesis, single lab\",\n      \"pmids\": [\"22252899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Polyalanine expansion mutations in ARX cause a marked reduction in Arx protein abundance in the developing forebrain without detectable protein aggregates; this reduced protein level correlates with impaired repression of target gene Lmo1, with greater loss of Lmo1 repression in the more severe PA1 (GCG7) expansion model than the PA2 (dup24) model.\",\n      \"method\": \"Knock-in mouse models; western blot; qRT-PCR of target gene expression\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two knock-in mouse models with protein quantification and target gene analysis, single lab\",\n      \"pmids\": [\"24122442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Arx is strongly expressed in differentiating embryonic (but not fetal) skeletal muscle downstream of myogenic bHLH genes; it co-immunoprecipitates with Mef2C, enhances myogenic differentiation when overexpressed in C2C12 cells, stimulates Myogenin promoter activity and E-box-driven transcription with MyoD and Mef2C, and its absence causes delayed embryonic myoblast differentiation in vivo.\",\n      \"method\": \"Co-immunoprecipitation; C2C12 overexpression; reporter/promoter assays; Arx-deficient embryo analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with Mef2C plus functional reporter assays and KO phenotype, single lab, multiple methods\",\n      \"pmids\": [\"17932502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Combined loss of Arx and Dnmt1 in mouse alpha-cells drives extensive conversion of alpha cells into progeny resembling native beta cells, with converted cells acquiring beta-cell electrophysiology and glucose-stimulated insulin secretion. In human T1D patients, subsets of glucagon-expressing cells show loss of DNMT1 and ARX and produce insulin.\",\n      \"method\": \"Lineage tracing; single-cell RNA sequencing; electrophysiology; GSIS assays; human tissue immunostaining\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including scRNA-seq, electrophysiology, and functional assays; replicated in human tissue\",\n      \"pmids\": [\"28215845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Postnatal Arx expression in parvalbumin interneurons (PVIs) regulates their functional properties; conditional postnatal ablation of Arx from PVIs increases theta oscillations, causes occasional seizures, elevated anxiety, and PVI hypoexcitability. Genome-wide sequencing of sorted PVIs identified Arx target genes associated with synaptic and extracellular matrix pathways.\",\n      \"method\": \"Conditional knockout (postnatal, PV-Cre); EEG recording; FACS-sorted cell RNA-seq; whole-cell patch-clamp recordings\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific conditional KO with EEG, electrophysiology, and genomic analysis, multiple orthogonal methods in single study\",\n      \"pmids\": [\"33490907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Chromatin immunoprecipitation combined with microarray analysis identified ~1006 gene promoters bound by Arx in neuroblastoma cells and mouse embryonic brain; ~24% of bound genes showed expression changes on Arx overexpression or knockdown, defining a broad ARX gene regulatory network.\",\n      \"method\": \"ChIP-chip (chromatin immunoprecipitation with microarray); mRNA expression microarray; Arx overexpression and knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP with expression validation, single lab\",\n      \"pmids\": [\"21966449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The C. elegans Arx ortholog alr-1 acts in a pathway with the LIM-homeodomain protein lin-11 (LIM1 ortholog) to regulate chemosensory neuron development, and alr-1 is required for differentiation of a GABAergic motoneuron subtype, demonstrating conservation of ARX function in GABAergic and sensory neuron development.\",\n      \"method\": \"C. elegans genetics; double mutant epistasis; neuronal cell fate analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in C. elegans with defined neuronal phenotypes, single model organism study\",\n      \"pmids\": [\"15790968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Neonatal estradiol (E2) administration prevents spasms and seizures in Arx(GCG)10+7 mice by altering mRNA levels of three Arx downstream targets (Shox2, Ebf3, and Lgi1) and restoring depleted interneuron populations, establishing that early transcriptional changes downstream of Arx are sufficient for lasting disease modification.\",\n      \"method\": \"Pharmacological treatment (E2) in Arx mutant mice; EEG; interneuron counts; qRT-PCR of Arx targets\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue with molecular mechanism via target gene normalization, single lab\",\n      \"pmids\": [\"24452264\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARX is a paired-type homeodomain transcription factor that functions primarily as a transcriptional repressor (and context-dependent activator) of downstream target genes; it is required cell-autonomously for GABAergic interneuron tangential migration, cortical progenitor proliferation via Cdkn1c repression, and cholinergic neuron development in the forebrain, where it acts downstream of Dlx2 and Lhx6 through ultraconserved enhancers; in the pancreas, antagonistic interactions between ARX and PAX4—each repressing the other's transcription—determine alpha- versus beta/delta-cell fate, with ARX maintained in the off-state in beta cells by Dnmt1-MeCP2-PRMT6-mediated epigenetic silencing; disease-causing mutations either abolish DNA binding and transcriptional repression (homeodomain missense mutations causing lissencephaly), reduce protein abundance (polyalanine expansions causing interneuronopathy and epilepsy), or sequester the nuclear import receptor IPO13 preventing proper nuclear distribution.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARX is a paired-type homeodomain transcription factor that orchestrates cell-fate specification and migration in two distinct developmental contexts: the forebrain and the pancreatic islet [#0, #1]. In the developing telencephalon, ARX is required cell-autonomously for tangential migration of ganglionic-eminence-derived GABAergic interneurons, cortical progenitor proliferation, and cholinergic neuron formation, acting downstream of Dlx2 and Lhx6, which bind ultraconserved forebrain enhancers in the ARX locus to drive its expression [#4, #5, #6, #16]. It functions principally as a sequence-specific transcriptional repressor, directly silencing Lmo1, Ebf3, Shox2, and the cell-cycle inhibitor Cdkn1c; de-repression of Ebf3 in ARX-deficient cells blocks interneuron migration, while loss of Cdkn1c repression causes premature progenitor cell-cycle exit [#7, #11, #12, #15]. Loss of ARX function specifically in cortical interneurons produces seizures and infantile-spasm-like events, and postnatal ARX in parvalbumin interneurons further tunes their excitability [#8, #24]. In the pancreas, ARX is necessary and sufficient to instruct alpha/PP-cell fate while suppressing beta- and delta-cell identity through mutually repressive antagonism with PAX4; in beta cells, the ARX locus is held silent by Dnmt1-dependent DNA methylation, MeCP2 binding, and PRMT6-mediated H3R2 methylation, and combined loss of ARX and Dnmt1 converts alpha cells into functional insulin-secreting beta-like cells [#1, #2, #3, #10, #23]. Disease mechanisms are stratified by mutation class: homeodomain missense mutations abolish DNA binding and repression (lissencephaly), polyalanine expansions reduce ARX protein abundance and target repression (interneuronopathy and epilepsy), and NLS mutations sequester the import receptor IPO13 to disrupt nuclear distribution [#11, #13, #21]. ARX can also act as a context-dependent activator, cooperating with FoxA2 to induce Shh at a floor-plate enhancer [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established ARX as essential for forebrain development by defining its requirement for GABAergic interneuron migration and neuronal proliferation, framing it as the molecular basis of a human brain malformation syndrome.\",\n      \"evidence\": \"Knockout mouse phenotypic analysis with human mutation identification\",\n      \"pmids\": [\"12379852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets not yet identified\", \"Upstream regulators of Arx expression unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended ARX function beyond brain to the pancreatic islet, showing it specifies alpha-cell fate through mutual transcriptional repression with PAX4.\",\n      \"evidence\": \"Gene-targeted knockout mouse, immunohistology, multiplex RT-PCR\",\n      \"pmids\": [\"14561778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to the Pax4 locus not demonstrated\", \"Cofactors mediating repression unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved the combinatorial logic of islet fate allocation by showing Arx and Pax4 together gate alpha/beta versus delta-cell identity, and conserved ARX neuronal function in an invertebrate.\",\n      \"evidence\": \"Mouse double-mutant genetic epistasis; C. elegans alr-1/lin-11 genetics\",\n      \"pmids\": [\"15930104\", \"15790968\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of somatostatin-cell default fate not defined\", \"Direct vs indirect cross-repression unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated ARX is sufficient, not merely necessary, to instruct alpha/PP fate, and revealed a separate role promoting embryonic myoblast differentiation via Mef2C.\",\n      \"evidence\": \"Conditional gain-of-function mouse with lineage tracing; C2C12 overexpression and Co-IP with Mef2C\",\n      \"pmids\": [\"17404619\", \"17932502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Muscle role rests on single lab\", \"Whether activation vs repression underlies myogenic effect unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placed ARX within a transcriptional hierarchy downstream of Dlx2 via ultraconserved enhancers and defined cell-autonomous progenitor proliferation and migration roles, plus its first direct repression targets.\",\n      \"evidence\": \"Enhancer functional characterization, Dlx gain/loss-of-function, in utero electroporation, genome-wide expression screen\",\n      \"pmids\": [\"18923043\", \"18509041\", \"17460091\", \"18799476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Repressive cofactor complexes not identified\", \"Direct binding for most dysregulated genes not confirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Causally linked ARX loss in interneurons to epilepsy and identified Ebf3 de-repression as a migration-blocking mechanism rescuable by Ebf3 silencing.\",\n      \"evidence\": \"Dlx5/6-CRE conditional knockout with EEG; ectopic-expression and epistasis rescue\",\n      \"pmids\": [\"19439424\", \"19627984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of seizure-relevant targets unresolved\", \"Circuit-level mechanism of spasms not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined a nuclear-import disease mechanism in which NLS mutations sequester IPO13, and identified TUBA1A interaction with a mitotic accumulation phenotype.\",\n      \"evidence\": \"Co-immunoprecipitation, immunofluorescence, cell-cycle analysis\",\n      \"pmids\": [\"20148114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TUBA1A interaction not reciprocally validated\", \"Functional consequence of mitotic accumulation in vivo unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the epigenetic logic silencing Arx in beta cells (Dnmt1-MeCP2-PRMT6), mapped upstream activators (Isl-1) and a genome-wide ARX regulatory network, and identified KDM5C as a target linking ARX to histone methylation.\",\n      \"evidence\": \"Conditional Dnmt1 KO with ChIP and lineage tracing; Isl-1 ChIP and mutagenesis; ChIP-chip in neuroblastoma/brain; KDM5C reporter and H3K4me3 assays\",\n      \"pmids\": [\"21497756\", \"21388963\", \"21966449\", \"23246292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ARX targets among ChIP-chip bound promoters mostly unvalidated\", \"Generality of epigenetic silencing model beyond beta cells unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined ARX biochemically as a repressor whose DNA-binding specificity depends on homeodomain-flanking residues, mechanistically explaining how homeodomain missense mutations cause disease.\",\n      \"evidence\": \"In vitro DNA-binding and luciferase repression assays with mutant analysis\",\n      \"pmids\": [\"22252899\", \"22194193\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of flanking-residue contribution not resolved\", \"Genome-wide binding motif not derived\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Mechanistically separated polyalanine-expansion pathology (reduced protein abundance impairing Lmo1 repression) from earlier aggregation models, identified Cdkn1c as a direct proliferation target, and established Arx inhibition alone as sufficient to trigger alpha-to-beta cell regeneration.\",\n      \"evidence\": \"Knock-in mouse models with western blot; cortex-specific conditional KO with profiling; conditional alpha-cell loss-of-function with lineage tracing\",\n      \"pmids\": [\"24122442\", \"23968833\", \"24204325\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation of aggregation vs abundance-loss models incomplete\", \"Cdkn1c regulation rests on single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Placed ARX downstream of Lhx6 in interneuron fate, revealed a context-dependent activator role with FoxA2 at the Shh floor-plate enhancer, and showed early target normalization (by estradiol) yields lasting seizure rescue.\",\n      \"evidence\": \"In vivo ChIP and MGE complementation; chick/mouse Shh enhancer perturbation; pharmacological E2 rescue with target qRT-PCR\",\n      \"pmids\": [\"24742460\", \"24968361\", \"24452264\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Switch between repressor and activator modes mechanistically undefined\", \"Cofactors converting ARX to an activator unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrated that combined ARX and Dnmt1 loss produces functional beta-like cells and that this conversion occurs in human type 1 diabetes islets, establishing translational relevance of ARX-controlled cell identity.\",\n      \"evidence\": \"Lineage tracing, scRNA-seq, electrophysiology, GSIS, human tissue immunostaining\",\n      \"pmids\": [\"28215845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stability and durability of converted cells unresolved\", \"Therapeutic targeting strategy not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed ARX has an ongoing postnatal role tuning parvalbumin interneuron excitability and identifying synaptic/ECM target pathways, extending its function beyond developmental specification.\",\n      \"evidence\": \"Postnatal PV-Cre conditional knockout, EEG, FACS-RNA-seq, patch-clamp\",\n      \"pmids\": [\"33490907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of synaptic/ECM targets unconfirmed\", \"Mechanism linking ARX loss to PVI hypoexcitability undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ARX switches between transcriptional repression and context-dependent activation, and which cofactor complexes mediate each mode at specific loci, remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of ARX bound to DNA or cofactors\", \"Identity of corepressor/coactivator complexes unknown\", \"Genome-wide direct target set across tissues incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 7, 11, 12, 15, 17, 20]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [11, 17, 18, 19, 20]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [11, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 13]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 4, 5, 6, 16]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 11, 12, 15, 20, 25]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 24]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [10, 19]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PAX4\", \"IPO13\", \"TUBA1A\", \"MEF2C\", \"DLX2\", \"LHX6\", \"FOXA2\", \"ISL1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}